Evidence map›Paper›PMID 41906594›Full record

ArticleEuropean journal of immunology2026

Post-Acute Sequelae Patients with Severe COVID-19 History Show a Prolonged Inflammatory, Vascular Injury Pattern.

Louisa Ruhl, Isabell Pink, Evgeny Chichelnitskiy, Nora Drick, Andrea Sauer, Lennart Boblitz, Kerstin Beushausen, Jana Keil, Anna-Lena Ullrich, Julius Schmidt and 4 more

Abstract read
In one paragraph

Article in European journal of immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Louisa RuhlInstitute of Transplant Immunology, Hannover Medical School, Hannover, Germany.
Isabell PinkDepartment of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany.
Evgeny ChichelnitskiyInstitute of Transplant Immunology, Hannover Medical School, Hannover, Germany.
Nora DrickDepartment of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany.
Andrea SauerDepartment of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany.
Lennart BoblitzDepartment of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany.
Kerstin BeushausenInstitute of Transplant Immunology, Hannover Medical School, Hannover, Germany.
Jana KeilInstitute of Transplant Immunology, Hannover Medical School, Hannover, Germany.
Anna-Lena UllrichInstitute of Transplant Immunology, Hannover Medical School, Hannover, Germany.ORCID 0000-0002-2874-5253
Julius SchmidtDepartment of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Marius M HoeperDepartment of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany.
Tobias WelteDepartment of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany.
Jenny F KühneInstitute of Transplant Immunology, Hannover Medical School, Hannover, Germany.
Christine S FalkInstitute of Transplant Immunology, Hannover Medical School, Hannover, Germany.

Funding

COFONI 4FF21COFONI 8FT21Federal Ministry of Education and Research (BMBF) 01KX2121Federal Ministry of Education and Research NUM 2.0Federal Ministry of Education and Research (BMBF) 01KX2121, NUM 2.0 COVIMGerman Centre for Infection Research TTU-IICH 07_913German Research Foundation DFG FA-483/1-1Lower Saxony Ministry of Research and Culture ImProVIT
6 · The paper itself

Abstract

SARS-CoV-2 infection can lead to persistent symptoms (i.e., long/post-COVID), especially in unvaccinated individuals. Little is known about the sustained impact of acute severe COVID-19 on immune signatures and long/post-COVID symptoms, often associated with cardiovascular events and pulmonary impairment. The longitudinal cohort (LC) was obtained from N = 46 patients with previous severe COVID-19 and prior to SARS-CoV-2 vaccination, collected over 5 visits up to 12 months after discharge (n = 139). Long/post-COVID status was assessed by lung function and fatigue scores. Blood was analysed regarding immune cell profiles, SARS-CoV-2 antibodies, and autoantigens. LC patients were compared with 39 acute severe COVID-19 ICU patients and 28 unexposed pre-pandemic donors (UE) and correlated with clinical parameters. LC patients exhibited long-term decreased CD4

Indexed as

COVID-19InflammationSARS-CoV-2AdultAgedAntibodies, ViralCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesFemaleHumansLongitudinal StudiesMaleMiddle AgedPost-Acute COVID-19 SyndromeAntibodies, Viralautoantibodiesendothelial injuryimmune cell profileinflammationlong/post‐Covidsoluble immune mediators

Identifiers

PMID41906594
PMCPMC13033956

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.